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The E2 glycoprotein of Sindbis virus is synthesized as a precursor, PE2, which is cleaved by furin or a
furin-like host cell protease at a late stage of maturation. The four-residue PE2 cleavage signal conforms to the
basic amino acid-X-basic-basic motif which is present in many other viral and cellular glycoproteins which are
processed by the cellular enzyme(s). In this report, we present evidence that the amino acid which immediately
follows the signal, the N-terminal residue of E2, can influence protease recognition, binding, and/or cleavage
of PE2. Constructs encoding nine different amino acids at E2 position 1 (E2 1) were produced by site-directed
mutagenesis of the full-length cDNA clone of our laboratory strain of Sindbis virus AR339 (pTRSB). Viruses
derived from clones encoding Arg (TRSB), Asp, Ser, Phe, His, and Asn in a nonglycosylated form at E2 1
contained predominantly E2. Viruses encoding Ile, Leu, or Val at E2 1 contained the uncleaved form of PE2.
The specific infectivity ofTRSB (E2 Arg-1) for baby hamster kidney (BHK-21) cells was from 5- to greater than
100-fold higher than those of isogenic constructs with other residues at E2 1, suggesting that E2 Arg-1
represents a BHK-21 cell adaptive mutation in our laboratory strain. In newborn CD-1 mice, TRSB was more
virulent than the PE2-containing viruses but less virulent than other PE2-cleaving viruses with alternative
amino acids at E2 1. These results indicate that in TRSB, E2 Arg-1 increased the efficiency of virus-cell
interactions in cultured BHK-21 cells but simultaneously decreased the ability of virus to mediate in vivo
virus-cell interactions critical for the induction of disease. This suggests that the N terminus of E2 may
participate in or be associated with virion domains which mediate these viral functions.
Many viral glycoproteins are derived from larger precursors
which are cleaved at specific sites during their maturation (63).
Proteolytic processing can be required for the export of these
proteins, for virus morphogenesis, and for the normal func-
tional properties of the released virus particles (see reference
8 and references within for review). For many enveloped RNA
viruses, including the alphaviruses (Togaviridae family), cleav-
age of the precursor is performed by a cellular protease(s) (24,
34, 61). Viral substrates for the host cell protease(s) contain a
highly conserved sequence motif which functions as the signal
for site-specific cleavage. This signal is similar in its arrange-
ment of basic amino acids to that found in specific membrane
and secretory proteins which are the natural cellular substrates
for the enzyme(s) (17). Alphaviruses provide a useful system
for analyzing the sequence requirements of the cleavage signal
itself, and for investigating how the cleavage event influences
specific steps in the normal viral replication cycle (15, 29, 46).
Alphaviruses are small, relatively simple, enveloped viruses
(49). The alphavirus genome consists of a positive-sense,
single-stranded RNA which is encapsidated within a T=4
nucleocapsid composed of 240 copies of capsid (C) protein (2,
39). The nucleocapsid is contained within a host cell-derived
lipid envelope (16). Two transmembranal, viral glycoproteins,
El and E2, are exposed on the surface of the virion (44,48). El
and E2 are associated as heterodimers, which in turn are
organized in groups of three to form the viral spikes (44). The
viral spikes form an icosahedral array at the virus surface and
are arranged with T=4 symmetry (11, 38, 57).
The structural proteins of alphaviruses are synthesized as a
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single polyprotein from which the glycoproteins PE2 (the E2
precursor) and El are cleaved while still nascent peptides (47).
PE2 and El form heterodimers in the rough endoplasmic
reticulum (44, 59, 64) and are processed and transported
through the exocytic pathway of the host cell (10). At a late
step in virus morphogenesis, PE2 is cleaved into E3 and E2
(21, 51). E3 is composed of the amino terminal 64 (Sindbis
virus) or 66 (Semliki Forest virus) amino acids of PE2. E3 is
lost to the medium from Sindbis virus-infected cells (62) but is
retained in the Semliki Forest virus particle (13). E2 represents
the remainder of PE2 and in mature virions, remains anchored
in the membrane in association with El.
Cleavage of PE2 occurs within a trans- or post-Golgi com-
partment and is likely performed by a host cell protease (7, 30,
61). The PE2 cleavage site immediately follows a highly
conserved canonical motif consisting of four residues ordered
in a basic-X-basic-basic (bxbb) sequence (43, 52). The residue
following this sequence, at E2 position 1 (E2 1), has not
previously been considered part of the cleavage signal. Serine
is found at E2 1 in Semliki Forest virus (12), Ross River virus
(3), Western equine encephalitis virus (14), Venezuelan
equine encephalitis (VEE) virus (23), Ockelbo virus (50), and
Sindbis virus S.A.AR86 (45) and in most laboratory strains
derived from Sindbis virus AR339 (50). In O'Nyong-nyong
virus, the E2 1 residue is Asn (27), and in Eastern equine
encephalitis virus the E2 1 residue is Asp (la). In our
laboratory strain of Sindbis virus AR339 (SB), cleavage follows
the sequence Arg-Ser-Lys-Arg, the last four residues of E3 (4).
The N terminus of the mature E2 glycoprotein (E2 1) is Arg,
as predicted by nucleotide sequencing (4) and as shown by
microsequencing of purified E2 from virions (1).
In this study, a panel of viruses containing different amino
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acid substitutions at E2 1 was constructed and the phenotypic
effects of these substitutions were determined. The results
indicate that the amino-terminal residue of E2 influences the
efficiency of PE2 cleavage, virion infectivity for baby hamster
kidney (BHK-21) cells, and virulence in vivo.
MATERIALS AND METHODS
Viruses and cell lines. Sindbis virus AR339 strain was ob-
tained originally from H. R. Bose (University of Texas, Aus-
tin). The parental virus used in these studies, TRSB, was
derived from an infectious, full-length cDNA clone (pTRSB)
containing viral sequences from our laboratory strain of
AR339 (SB) placed downstream of an SP6 phage promoter
(29a). The prefix TRSB was assigned to mutant viruses con-
structed in pTRSB. Biologically derived mutants lack this
prefix. Two biologically derived mutants, N7R1 and N7R2,
have been described previously (15). N7R1 contains an Asn
substitution at E2 1 and a Thr-to-Pro substitution at E2 3.
N7R2 contains an Asp substitution at E2 1. For consistency
with the virus nomenclature used in this study, these viruses
have been renamed E2N1 and E2D1, respectively. All virus
stocks used in this study were produced by electroporation of
in vitro transcripts from the cDNA clone into BHK-21 cells as
described previously (15, 28). BHK-21 cells were maintained in
supplemented Eagle's minimal essential medium (Gibco-BRL)
(15). The construction and characterization of the full-length
cDNA clone pTRSB-N also has been described before (15).
In vitro mutagenesis. Specific mutations were constructed in
the genetic background ofpTRSB by site-directed mutagenesis
(25). Single codon substitutions were engineered into the E2 1
locus of pTRSB to produce viruses containing Ile (TRSB-
E211), Val (TRSB-E2V1), Leu (TRSB-E2L1), Phe (TRSB-
E2F1), or Ser (TRSB-E2S1). A Lys-to-Asn substitution at the
E2 207 locus of pTRSB was made to produce TRSB-E2N207.
Mutagenesis was performed as described previously (40, 41),
using the M13-derived mutagenesis vector mpl8SBGP and
site-specific mutagenesis primers, each containing one or two
mismatched nucleotides. mpl8SBGP contains the PE2, 6K,
and El gene sequences of SB. The screening of individual
phage clones and replacement of restriction fragments from
phage replicative-form DNA into pTRSB were conducted as
described elsewhere (15). Each recombinant pTRSB was se-
quenced across the entire replacement region by the Taq cycle
sequencing procedure (United States Biochemical).
cDNA construction of revertant genotypes by PCR. Muta-
tions present in the biologically derived revertant viruses
E2N1, E2D1, and E2H1 were identified by direct sequencing
of virion RNA as described previously (4, 65). A reverse
transcriptase-PCR procedure was used to obtain double-
stranded DNA fragments containing these mutations. Briefly,
viral RNA from each mutant was purified as described previ-
ously (15) and served as template for cDNA synthesis using
reverse transcriptase and a complementary sense primer. This
cDNA was amplified by PCR (20 cycles) using Taq DNA
polymerase and a viral sense return primer. PCR fragments
were digested with restriction enzymes, replaced into pTRSB,
and sequenced (15).
In vitro transcriptions and transfection of cells. In vitro
transcripts were routinely introduced into BHK-21 cells by
electroporation for the production of virus stocks and for
metabolic labelling of virus particles for sodium dodecyl sulfate
(SDS)-polyacrylamide gel electrophoresis (PAGE) analysis as
described elsewhere (15, 28). The specific infectivity was
determined for in vitro transcripts derived from each construct
(15). Briefly, transcripts were labelled in vitro with 35S-UTP,
spotted onto DE-81 ion exchange paper (Whatman), and
quantitated on a liquid scintillation counter. A duplicate
sample of unlabelled transcripts was transfected into BHK-21
cells with Lipofectin reagent (Gibco-BRL), and the cells were
overlaid with agarose. Plaques were visualized 30 to 48 h later
by staining with neutral red. Specific infectivity values were
calculated as PFU/counts per minute.
Specific infectivity assay for virions. The relative abilities of
TRSB and each mutant virus to initiate infection of BHK-21
cells were determined in a specific infectivity assay. [35S]me-
thionine-labelled virions were purified from infected BHK-21
cells as described below. Duplicate aliquots of each sample
were precipitated with trichloroacetic acid and quantitated by
liquid scintillation counting, and the values obtained were
averaged. Values were adjusted for the additional E3 methio-
nine present in non-PE2-cleaving viruses (26 total) and absent
from PE2-cleaving viruses (25 total). Infectious particles were
quantitated by a standard plaque assay on BHK-21 cell mono-
layers. The specific infectivity of each preparation was calcu-
lated as total PFU/counts per minute plated.
Polyacrylamide gel analysis of [35S]methionine-labelled vi-
ral proteins. Virion proteins were radiolabelled with [35S]me-
thionine and resolved by SDS-PAGE. BHK-21 cell monolayers
were infected with virus at a multiplicity of infection of 2 to 5
PFU per cell or electroporated with in vitro transcripts. Viral
proteins were labelled with [35S]methionine (final concentra-
tion, 10 ,uCi/ml) as described elsewhere (15). Labelled virions
were purified from supernatants by sequential banding on
discontinuous and continuous potassium tartrate gradients (20
to 35%) as described previously (37, 45). Labelled viral pro-
teins were resolved by SDS-PAGE (10% acrylamide gels)
under reducing conditions (50 mM 2-mercaptoethanol) (26)
and visualized by autoradiography.
Studies of virulence in newborn CD-1 mice. Each infectious
virus was assayed for virulence in litters of 1-day-old CD-1
mice (Charles River). Two to four litters of newborn mice
(<24 h old) were infected with 100 PFU of virus in 50 [lI of
phosphate-buffered saline (PBS; without Mg2+ or Ca2+) plus
1% donor calf serum (PBS-D 1%) per mouse by subcutaneous
inoculation. Two control mice from each litter were inoculated
with 50 RI of PBS-D 1% only. Mice were observed daily for 14
days. Values were calculated for percent mortality and average
survival times (AST) for the animals that died. Viruses causing
100% mortality with AST the same as or less than that for
TRSB were considered virulent; those causing <100% mortal-
ity were considered attenuated.
RESULTS
Isolation and characterization of N7R4. Site-directed mu-
tagenesis of a Sindbis virus AR339 cDNA clone (pTRSB) was
used previously to substitute Asn for Arg at E2 1 (15), to model
a mutation found in an attenuated variant of Sindbis virus
S.A.AR86 (45). In pTRSB, the mutation created a site for
N-linked glycosylation (Asn-X-Thr). Full-length in vitro tran-
scripts were introduced into BHK-21 cells by electroporation.
Carbohydrate addition at E2 1 effectively prevented PE2
cleavage and resulted in the production of PE2-containing
particles (TRSB-N) which were efficiently assembled and
released but which were noninfectious. Eight infectious rever-
tants of TRSB-N were isolated, and seven were characterized
(15). Two of these revertants had mutations that abrogated the
glycosylation signal and restored PE2 cleavage. Five of the
revertants retained the PE2 cleavage defect and had incorpo-
rated a suppressor mutation(s) in either E3 or E2. Here, we
present a genetic and phenotypic characterization of the eighth
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TABLE 1. Genotypic and phenotypic properties of
TRSB and mutant viruses
Virus type and clone E2 1 PE2 cleavage
Viruses containing E2 Arg-1












As determined by SDS-PAGE analysis of purified virions.
b TRSB-E2N207 and TRSB-N7R4 also contain an E2 Asn-207 substitution.
TRSB-E2N1 also contains an E2 Pro-3 substitution.
a.
FIG. 1. SDS-PAGE analysis of purified viruses. Virions were met-
abolically labelled with [35S]methionine and purified from infected
BHK-21 cell supernatants as described in the text. "4C-methylated
proteins (far left lane) marked (in thousands) on the left side of the gel
were included as molecular weight markers. (Panel a) Lane A, TRSB;
lane B, TRSB-N; lane C, TRSB-N7R4. (Panel b) Lane A, TRSB-E2I1;
lane B, TRSB-E2N207. C, capsid protein.
revertant, N7R4, and of a panel of mutant viruses, each
containing a different amino acid at E2 1.
The putative reverting mutation(s) in N7R4 was identified
by sequencing N7R4 virion RNA across the E3 and E2 genes.
Two mutations were identified: an Ile for Asn at E2 1, and an
Asn for Lys at E2 207. Like one class of revertants (E2N1 and
E2D1) described previously (15), the mutation at E2 1 elimi-
nated the N-linked glycosylation signal at this site. This is
reflected in the wild-type mobility of PE2 in SDS-PAGE (Fig.
1). However, unlike these revertants, N7R4 retained the PE2
cleavage defect and incorporated PE2 in place of E2 in virions.
To confirm that one or both of these mutations were respon-
sible for the revertant phenotype of N7R4, the genotype of
N7R4 was reconstructed in pTRSB by a reverse transcriptase-
PCR cloning procedure as described in Materials and Meth-
ods. Virus (TRSB-N7R4) derived from this clone (pTRSB-
N7R4) recapitulated the PE2 glycosylation and cleavage
phenotypes of N7R4 as determined by SDS-PAGE (data not
shown).
The influence of the two individual mutations on PE2
cleavage and revertant phenotypes of N7R4 was determined by
constructing each mutation singly in pTRSB by site-directed
mutagenesis. Virus containing only the E2 Asn-207 mutation
(TRSB-E2N207) cleaved PE2 and incorporated E2/E1 het-
erodimers into virions (Fig. 1). TRSB-E2N207 and TRSB
produced large, comparably sized plaques on BHK-21 cells.
Virus containing only the E2 Ile-1 mutation (TRSB-E211)
failed to cleave PE2, and incorporated PE2/E1 heterodimers in
virions (Fig. 1). TRSB-E2I1 produced extremely small plaques
on BHK-21 cells. N7R4 and TRSB-N7R4 each produced
plaques of intermediate size on BHK-21 cells. These results
indicated that the E2 Ile-1 mutation alone was responsible for
the PE2 cleavage defect of N7R4 and was sufficient for the
reversion to viability as defined by the specific infectivity of
transcripts containing this mutation. However, both mutations
were required for expression of the intermediate-plaque-size
phenotype of N7R4, suggesting that E2 Asn-207 provided an
additional selective growth advantage on BHK-21 cells.
Influence of the E2 1 residue on PE2 cleavage. As demon-
strated by TRSB-N, N-glycosylated Asn at E2 1 was not
compatible with PE2 cleavage. However, PE2 cleavage oc-
curred when the E2 1 residue was Asn in a nonglycosylated
form (in E2N1 which has E2 Asn-1 plus E2 Pro-3), Asp
(E2D1), or Arg (TRSB) (15). To address the possibility that
amino acids other than Ile at E2 1 also were incompatible with
PE2 cleavage, the PE2 cleavage phenotype was determined for
seven additional viruses, each derived from a construct in
pTRSB and each with a different amino acid at E2 1 (Table 1).
The PE2 cleavage phenotype of each virus was determined
by the amount of PE2 present in purified virions (Fig. 2). The
amino acids Arg, Asp, Ser, Phe, His, and Asn (nonglycosy-







FIG. 2. SDS-PAGE analysis of wild-type virus (TRSB) and viable
E2 1 mutants. Viruses were metabolically labelled with [35S]methi-
onine and purified from infected BHK-21 cell supernatants as de-
scribed in Materials and Methods. 14C-methylated proteins (far left
lane) marked (in thousands) on the left side of the gel were included
as molecular weight markers. Lane A, TRSB; lane B, TRSB-E2N1;
lane C, TRSB-E2D1; lane D, TRSB-E2S1; lane E, TRSB-E2H1; lane
F, TRSB-E2F1; lane G, TRSB-E2L1; lane H, TRSB-E2I1; lane I,
TRSB-E2V1.
J. VIROL.
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TABLE 2. Specific infectivities of TRSB and mutant viruses
for BHK-21 ceilsa
Virus type and clone E2 1 Specificinfectivity(%
Viruses containing E2 Arg-1
TRSB Arginine 100
TRSB-E2N207 Arginineb 170
E2 1 mutants (PE2 cleaving)
TRSB-E2N1 Asparaginec 3










a Viruses were labelled with [35S]methionine and purified from infected
BHK-21 cell supematants as described in Materials and Methods. Virus prepa-
ration titers were determined by plaque assay on BHK-21 cell monolayers.
Specific infectivity values were calculated as PFU/counts per minute and
presented as a percentage of the specific infectivity for TRSB (100%). Values are
the averages for two experiments.
b TRSB-E2N207 and TRSB-N7R4 also contain an E2 Asn-207 substitution.
c TRSB-E2N1 also contains an E2 Pro-3 substitution.
lated) at E2 1 specified the PE2 cleavage phenotype. Each
virus incorporated predominantly E2/E1 heterodimers into
virions, although a small amount of PE2 was present in each
(Fig. 2). Extremely inefficient cleavage of PE2 was apparent in
viruses containing Ile, Val, or Leu at E2 1, and these viruses
incorporated PE2/E1 heterodimers almost exclusively (Fig. 2).
Clearly, certain amino acids at E2 1, specifically those with
branched aliphatic side chains, can prevent protease recogni-
tion, binding, and/or activity at the PE2 cleavage signal. In
contrast to TRSB-N particles, which were essentially noninfec-
tious, these PE2-containing viruses were viable in the absence
of resuscitating mutations.
Specific infectivity of TRSB and E2 1 mutant viruses. With
the exception of the pTRSB-N mutation, none of the amino
acids substituted at E2 1 was lethal, as determined by the
specific infectivity of in vitro transcripts (data not shown).
However, the E2 1 substitutions did affect the biological
properties of the released virions. The specific infectivity of
each viable virus was determined as an average of two inde-
pendent experiments and is presented as a percentage of the
TRSB specific infectivity (100%) (Table 2).
TRSB and TRSB-E2N207 virions, which both contain Arg at
E2 1, displayed the highest specific infectivity for BHK-21 cells.
Surprisingly, the specific infectivities of all other PE2-cleaving
viruses were dramatically reduced (< 1 to 3% relative to that of
TRSB). Similarly, the specific infectivity of each PE2-contain-
ing virus also was lower than that of TRSB. The specific
infectivity of TRSB-E2I1 was only 7% that of TRSB. However,
the specific infectivity of TRSB-N7R4, which also contains the
E2 Asn-207 mutation, increased to 56% that of TRSB. The
specific infectivities of TRSB-E2L1 and TRSB-E2V1 (PE2
cleavage defective) were consistently higher than those for all
PE2-cleaving viruses except those with E2 Arg-1. Therefore, a
direct relationship between the efficiency of PE2 cleavage and
specific infectivity in BHK-21 cells was not observed. Instead,
these results suggested that the differences in specific infectiv-
ity were directly related to the influence of the amino-terminal
residue of E2. This region of E2 likely participates in one or
more spike functions related to infectivity in BHK-21 cells,
even when in the context of PE2.
Virulence ofTRSB and E2 1 mutant viruses in mice. Each of
the viruses containing alternative amino acids at E2 1 was
inoculated into newborn mice to determine if differences in
specific infectivity on BHK-21 cells or PE2 cleavage phenotype
correlated with differences in virulence in mice.
Consistent with our previous studies, the PE2 cleavage
defective and attenuation phenotypes were directly linked.
Each PE2-containing virus was attenuated, causing between 59
and 93% mortality and ASTs ranging from 5.2 to 9.5 days
(Table 3). The values for TRSB-E2L1 and TRSB-E2V1 were
similar to those obtained previously for the PE2-containing
revertants of TRSB-N (15). TRSB-E211, although causing less
than 100% mortality, was the most virulent of this group, and
the AST for those animals succumbing to infection (5.4 days)
was markedly shorter than for any other PE2 cleavage-defec-
TABLE 3. Virulence of TRSB and mutant viruses in newborn mice
Virus type and clone (no. of animals) % Mortality Rangea (dasT)b Virulence'
Viruses containing E2 Arg-1
TRSB 3 (31) 100 NA 4.1 ± 0.6 Virulent
TRSB-E2N207 2 (22) 100 NA 4.6 ± 0.7 Virulent
E2 1 mutants (PE2 cleaving)
TRSB-E2N1 3 (27) 100 NA 2.8 ± 0.4 Virulent
TRSB-E2D1 3 (29) 100 NA 2.6 ± 0.5 Virulent
TRSB-E2H1 4 (38) 100 NA 2.7 ± 0.7 Virulent
TRSB-E2S1 3 (34) 100 NA 2.3 ± 0.4 Virulent
TRSB-E2F1 3 (30) 100 NA 2.8 ± 0.4 Virulent
E2 1 mutants (PE2 cleavage defective)
TRSB-E2L1 4 (38) 61 20-89 8.4 ± 3.0 Attenuated
TRSB-E2V1 4 (44) 61 40-77 8.0 ± 2.8 Attenuated
TRSB-E211 4 (42) 93 83-100 5.2 ± 3.0 Attenuated
TRSB-N7R4 2(29) 59 45-67 9.5 ± 2.4 Attenuated
a Range indicates percent mortality values for litters having the lowest and highest percent mortality rates. NA, not applicable.
b AST ± standard deviations for animals that died.
Virulent, causing 100% mortality of infected animals. Attenuated, causing <100% mortality.
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tive virus. When combined with the E2 Asn-207 mutation, an
E2 Ile-1-containing virus (TRSB-N7R4) displayed virulence
characteristics similar to those of other attenuated PE2-con-
taining viruses (59% mortality and an AST of approximately
9.5 days).
Each of the PE2-cleaving viruses caused 100% mortality.
The ASTs for viruses having an amino acid other than Arg at
E2 1 (2.3 to 2.8 days) were significantly lower than those for E2
Arg-1-containing viruses (TRSB and TRSB-E2N207; by t test,
P < 0.001 for each). The inoculating dose for each virus in this
experiment was based on PFU assayed in BHK-21 cells.
However, the actual number of virus particles in each animal
inoculum varied in proportion to the specific infectivity of each
virus in BHK-21 cells. Therefore, the decreased AST associ-
ated with each PE2-cleaving, position 1 mutant may actually
reflect the effect of a higher dose in terms of virus particles. To
address this possibility, four litters of newborn CD-1 mice (34
animals) were inoculated subcutaneously with an average of
1.0 PFU per mouse of TRSB-E2S1, an infecting dose designed
to approximate, in numbers of virus particles, a dose of 100
PFU of TRSB. These infections resulted in 100% mortality
and an AST of 2.8 ± 0.4 days. The difference in AST between
1 BHK-21 cell PFU of TRSB-E2S1 and 100 PFU of TRSB was
statistically significant (by t test, P < 0.001). This indicates that
the reduced ASTs for PE2-cleaving, position 1 mutants reflect
actual differences in virulence and strongly suggests that the
virulence of Sindbis virus AR339 can be influenced directly by
the amino-terminal residue of E2.
DISCUSSION
The results presented in this report provide additional
information about the amino acid sequence motif constituting
the PE2 cleavage signal, biological functions of the amino
terminus of E2, and the relationship of cell culture adaptation
to reduction of virulence in vivo.
Nature of the PE2 cleavage signal. The bxbb amino acid
motif immediately upstream of the PE2 cleavage site is the
major constituent of the cleavage signal. Cleavage of PE2 from
Semliki Forest virus was prevented by mutating the amino acid
at the -1 position relative to the cleavage site (29, 46).
Insertional mutagenesis of the bxbb signal in Sindbis virus
resulted in the production of PE2-containing virions (9). In
addition, PE2-containing virions were produced by passage of
Sindbis virus in a cell line (RPE.40) that is defective in a
protease which recognizes the bxbb motif and is responsible for
PE2 cleavage (30, 31, 61). It has now been shown that
substitution of amino acids with branched aliphatic side chains
(Ile, Leu, or Val) at the + 1 position relative to the bxbb motif
also prevents PE2 cleavage.
The mechanism by which these particular substitutions
prevent cleavage is unknown. A global effect on PE2 confor-
mation, whereby folding of the precursor containing Ile, Leu,
or Val at E2 1 occluded the bxbb signal motif, cannot be ruled
out. However, it is unlikely that the hydrophobicity of these
residues, or their potential for sterically hindering access to the
bxbb motif locally, accounts for their inhibition of PE2 cleav-
age. Another hydrophobic substitution, E2 Phe-1, was compat-
ible with efficient PE2 cleavage. Also, Phe, Arg, and His
residues, which were permissive for PE2 cleavage, are equal to
or greater in size than Ile, Leu, and Val.
Alternatively, the E2 1 residue may contribute to the cleav-
age signal itself, which would suggest that Ile, Leu, or Val at
this locus prevents effective recognition of the bxbb signal by
the cellular protease. Likewise, other substitutions at E2 1,
such as Ser and His, increase the efficiency of PE2 cleavage
relative to that of E2 Arg-1 in TRSB. Enzymatic activity of the
cellular protease(s) can be inhibited by analogous amino acid
substitutions in the context of a variety of viral and cellular
substrates. In Newcastle disease virus (Paramyxoviridae fami-
ly), processing of the precursor Fo to F1 and F2 was inhibited
by a Phe-to-Leu substitution at the site analogous to E2 1 (32),
and Leu occupies this locus in many avirulent strains of
Newcastle disease virus which contain an uncleaved Fo protein
(54, 55). Cleavage of the cellular precursor polypeptide
proalbumin was prevented if Glu at the + 1 position relative to
the cleavage signal was replaced by Leu, Val, or Ile (35). These
findings support the hypothesis that the + 1 residue relative to
the cleavage site contributes to the signal itself and that amino
acids with branched aliphatic side chains are not compatible
with protease recognition, binding, and/or cleavage.
Influence of the E2 amino terminus on alphavirus spike
function. Phenotypic comparisons between TRSB and the E2 1
mutant viruses which are PE2 cleavage competent suggest that
the amino-terminal residue of E2 influences and/or partici-
pates in one or more functions of the glycoprotein spike. TRSB
virions (E2 Arg-1) were approximately 30- to 250-fold more
infectious in BHK-21 cells than viruses containing any of the
other E2 1 amino acids. This suggests that E2 Arg-1 provides
a selective advantage to the infecting virion in these particular
cells. In most strains of Sindbis viruses and closely related
Sindbis-like viruses, the E2 1 amino acid is Ser (5, 45, 50). E2
Arg-1, present in our laboratory strain of Sindbis virus AR339
(SB), is an exception and may have been selected during
passage of SB on BHK-21 cells. The high specific infectivity of
TRSB virions may reflect enhanced binding to BHK-21 cell
receptors or more efficient internalization and uncoating.
Several reports support the hypothesis that the amino terminus
of E2 participates in these events. Tandem mutations at E2 3
and E2 4 were linked to rapid penetration of BHK-21 cells in
the related alphavirus VEE virus (6, 20). The rapid penetration
phenotype of a Sindbis virus S.A.AR86 mutant, S12, also was
linked to a substitution at E2 1 which prevented PE2 cleavage
(45). Dubuisson and Rice (9) demonstrated that insertions
near the PE2 cleavage site of Sindbis virus produced mutants
which were defective for binding to BHK-21 cells and chicken
embryo fibroblasts and which also exhibited slower penetration
kinetics. These results implicate domains composed of or
including the N terminus of E2 as participating in alphavirus
binding and penetration.
Domains on the alphavirus glycoprotein spike which partic-
ipate in receptor interactions have been identified indirectly as
a result of using anti-idiotype approaches to identify cellular
receptors for Sindbis virus (56, 60). One of the monoclonal
antibodies used in these studies binds to the E2a neutralization
site and yields monoclonal antibody escape mutations at E2
214 (53). Two observations suggest an association of the amino
terminus of E2 with the alphavirus major neutralization do-
main (E2 181 to 216 in Sindbis virus [53], E2 180 to 210 in VEE
virus [19], and E2 216 to 251 in Ross River virus [22, 58]).
Peptides representing the amino terminus of VEE virus E2
elicit protective antibodies which compete for binding to
virions with monoclonal antibodies directed to the major
neutralizing domain (18). In addition, second-site mutations in
Sindbis virus E2, which increase the specific infectivity of
cleavage-defective viruses for BHK-21 cells, all map between
E2 residues 191 and 239 (15). These observations are consis-
tent with the phenotypes of mutations at or near the E2 amino
terminus and suggest that it may participate in or be associated
with virion domains important for receptor binding and other
early events in infection. Failure to cleave PE2, therefore, may
restrict the normal function of the E2 amino terminus.
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The amino acid at E2 1 also influenced virulence in newborn
mice, either directly as the amino-terminal residue of E2 or by
preventing PE2 cleavage. In those viruses whose E2 1 substi-
tution inhibited PE2 cleavage, virulence was reduced. This is
consistent with the previous finding that a PE2 cleavage-
defective phenotype was correlated with decreased virulence in
animals (15, 42, 45). The surprising result was that mutants
with E2 1 substitutions which allowed PE2 cleavage were
significantly more virulent than virus derived from the TRSB
clone. This may reflect the increased efficiency of PE2 cleavage
observed with most of these substitutions. However, nonglyco-
sylated E2 Asn-1 was approximately as efficient as E2 Arg-1 in
terms of PE2 cleavage, yet virus with the former mutation was
significantly more virulent than that with the latter in neonatal
mice. Alternatively, the increase in virulence may be a conse-
quence of the seemingly inverse relationship between efficiency
of growth on cultured cells and virulence in vivo (see reference
33 for a review). Compared with the E2 Ser-1 virus, which has
the consensus amino acid at this locus, the E2 Arg-1 virus had
a higher specific infectivity for BHK-21 cells and allowed
extended survival in mice. A similar inverse relationship is
evident in a comparison of virus containing E2 Ile-1 and virus
containing E2 Asn-207 in the E2 Ile-1 background. Mutations
which increase the efficiency of virus-cell interactions with
BHK-21 cells in culture may simultaneously decrease the
ability of these viruses to mediate in vivo virus-cell interactions
critical for the induction of disease. These data are consistent
with previous studies of Sindbis virus and VEE virus which
demonstrate that selection for efficient growth on BHK-21
cells strongly coselects for attenuation in vivo (20, 36, 45).
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